Apellis Pharmaceuticals, Inc.
COMPLEMENT INHIBITOR DOSING REGIMENS
Last updated:
Abstract:
Methods and compositions for inhibiting complement are described.
Status:
Application
Type:
Utility
Filling date:
17 Jul 2020
Issue date:
8 Sep 2022